Advance Venture Partners

VCMatch tracks Advance Venture Partners as an investor focused on Agtech, Healthtech, and Biotech companies, Pre-Seed and Seed rounds, Silicon Valley, California, and United States markets, and $50k to $20m check sizes. Upload your deck to compare your startup against the full private matching profile.

Check Size

$50k to $20m

Stages

Pre-Seed, Seed, Series A, Series B, Series C, Growth

Focus Areas

Agtech, Healthtech, Biotech

Geography

Silicon Valley, California, and United States

Investment Thesis

Advance Ventures positions itself as a hands-on, founder-focused seed and early-stage investor and accelerator that helps entrepreneurs “take bold risks, build great companies and achieve meaningful exits.” The firm emphasizes investing in “leading edge companies in emerging high growth markets” and typically partners “in tandem with top-tier venture funds,” taking “a very active role in a company’s day-to-day operations as directors, board observers and advisors” to create long-term value by leveraging its experience and contacts.

Is Advance Venture Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Advance Venture Partners is most relevant for founders raising Pre-Seed, Seed, and Series A rounds in Agtech, Healthtech, Biotech, and Medtech, especially across Silicon Valley, California, and United States, with public check-size signals around $50k to $20m.

Focus statement

Advance Ventures focuses on seed and early-stage, disruptive startups across emerging high-growth markets (notably life sciences / healthtech, AgTech, food/ingredient tech and biosciences) and often co-invests with top-tier venture funds while providing accelerator-style, hands-on operational support.

Value Add

Founded in 1999 by a "unique team of proven entrepreneurs, company operators and venture capitalists" — institutional memory and operator DNA that inform investments.
Acts as both a venture fund and a venture accelerator (fund + accelerator model).
Takes a highly active, day-to-day role in portfolio companies: "directors, board observers and advisors."
Emphasizes dedicated time and domain expertise: "dedicating significant time to each portfolio company and leveraging deep domain expertise in our investment sectors."
Explicit track record orientation: claims to have "consistently achieved meaningful exits" across core sectors.
Syndication and network-first approach: invests "in tandem with top-tier venture funds," leveraging broad contacts and events/industry engagement (panels, conferences).